-
MHRA to consult on potential for no-deal Brexit
pharmafile
November 20, 2018
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would be impacted by a no-deal Brexit.
-
Cases of measles nearly quadruple since last year in UK
pharmatimes
November 14, 2018
Public Health England is urging the public to ensure that they have received two doses of the MMR vaccine after it was revealed that there were more than 913 cases
-
Medical cannabis made available on prescription in the UK
europeanpharmaceuticalreview
November 02, 2018
Medical cannabis is now avaliable through the NHS, but many are warning about its drawbacks and that it won’t be available for those who need it…
-
UK Dementia partnership offering £100,000-200,000 awards for dementia research projects
pharmafile
October 25, 2018
The Dementia Discovery Fund (DDF) in partnership with the UK Dementia Research Institute (UK DRI) has announced that it will provide a series of awards between £100,000 and £200,000...
-
Researchers warn of impact of no-deal Brexit on UK science
pharmaceutical-technology
October 24, 2018
UK biomedical research lab Francis Crick Institute has warned that a hard or ‘no-deal’ Brexit could negatively impact the science and research across the country.
-
MHRA to extend EpiPen expiry dates to tackle shortages
pharmafile
October 19, 2018
The British government has extended the expiry date on epinephrine pens amid a shortage in the UK.
-
UK regulator declines Roche MS drug
biospectrumasia
October 15, 2018
The drug got EU marketing authorization in January, leaving it to member states to decide whether to provide the treatment
-
Life expectancy growth stalls for the first time since 1982
pharmatimes
September 27, 2018
Life expectancy in the UK has stopped increasing for the first time since 1982, show new data released by the Office for National Statistics.
-
Protecting the links between the UK and the EMA
cphi-online
August 15, 2018
Now less than a year away from when the UK officially leaves the EU, the main goal remains the same - maintaining access to new drugs for patient health.
-
UK prepares to stockpile medical supplies for possible no-deal Brexit
pharmaceutical-technology
July 30, 2018
The British Medical Association (BMA) has announced that the UK Government is considering stockpiling of medical supplies in case the country does not secure a relevant deal before exiting the European Union (EU) in 2019.